Hipras Chemicals And Pharmatech Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 6 Year, 10 Months
- Last Filing with ROC 31 Mar 2020
- Revenue Growth %
- Profit Growth 179.25%
- Ebitda 179.25%
- Net Worth 30.36%
- Total Assets 364.91%
About Hipras Chemicals And Pharmatech
Hipras Chemicals And Pharmatech Private Limited (HCAPPL) is a Private Limited Indian Non-Government Company incorporated in India on 21 March 2018 (Six years and ten months 21 days old ). Its registered office is in Thane, Maharashtra.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2020. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Asif Shaikh and Mohar Bhattacharya serve as directors at the Company.
Company Details
-
LocationThane, Maharashtra
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U74999MH2018PTC306908
-
Company No.
306908
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
21 Mar 2018
-
Date of AGM
31 Dec 2020
-
Date of Balance Sheet
31 Mar 2020
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
What products or services does Hipras Chemicals And Pharmatech Private Limited offer?
Hipras Chemicals And Pharmatech Private Limited offers a wide range of products and services, including Industrial Chemicals & Supplies, Chemical Intermediates.
Who are the key members and board of directors at Hipras Chemicals And Pharmatech?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mohar Bhattacharya
|
Additional Director | 11-Dec-2018 | Current |
|
Asif Shaikh
|
Director | 21-Mar-2018 | Current |
Financial Performance of Hipras Chemicals And Pharmatech.
Hipras Chemicals And Pharmatech Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 179.25% increase in profit. The company's net worth Soared by an impressive increase of 30.36%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Hipras Chemicals And Pharmatech?
In 2020, Hipras Chemicals And Pharmatech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Hap Gantry And Engineering Services Private LimitedAsif Shaikh and Mohar Bhattacharya are mutual person
-
Hap India Marine Engineering Services Ll PAsif Shaikh is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Hipras Chemicals And Pharmatech?
Unlock and access historical data on people associated with Hipras Chemicals And Pharmatech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Hipras Chemicals And Pharmatech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Hipras Chemicals And Pharmatech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
